Eisai Co., Ltd. Skip Navigation Top menu Japanese | English
| Sitemap |
Main menu  Investor Relations  |  Environmental and Social Report  |  about Eisai  |  Inquiry
    Home > Investor Relations > Understanding Eisai > Eisai Glossary
Understanding Eisai
Side menu
Six Easy-to-understand Points
1 Minute Guide to 6 Key Points
1. Understanding Products
2. Understanding Strengths
3. Understanding Research and Development
4. Understanding the Future
5. Understanding Business Results
6. Understanding Management

Introduction to Eisai Shares
Understanding the Pharmaceutical Industry

Eisai Glossaryselected

Useful Information
Company Introduction Video

Understanding Eisai Sitemap
Main contents

Eisai Glossary
Introducing expressions used in Understanding Eisai.

Alphabetical Search
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z        


Search by category
Eisai product names New Eisai pharmaceuticals under development
Eisai's businesses Pharmaceuticals/treatments
Accounting  

A
Acetylcholin-esterase inhibitorOpen a separeate window
AcipHex®Open a separeate window
Actonel®Open a separeate window
AdjustedOpen a separeate window
Aloxi®Open a separeate window
ANDAOpen a separeate window
Aricept® Open a separeate window
Page Top

B
BlockbusterOpen a separeate window
Branded drugOpen a separeate window
Page Top

C
Cash IncomeOpen a separeate window
ComplianceOpen a separeate window
Compound (of matter) patentOpen a separeate window
Page Top

D
Dacogen®Open a separeate window
DOEOpen a separeate window
Dramatic Leap PlanOpen a separeate window
Drug priceOpen a separeate window
Page Top

E
E2007Open a separeate window
E2012Open a separeate window
E5564Open a separeate window
E7389Open a separeate window
Eril®Open a separeate window
European Knowledge CentreOpen a separeate window
Page Top

G
GAAPOpen a separeate window
Gasmotin®Open a separeate window
GenericsOpen a separeate window
Glufast®Open a separeate window
Page Top

h
Humira®Open a separeate window

I
In Process R&D ExpensesOpen a separeate window
Independent MarketingOpen a separeate window
Inovelon®Open a separeate window
Integrative neuroscienceOpen a separeate window
Integrative oncologyOpen a separeate window
Page Top

K
KES524Open a separeate window
Page Top

M
Managed careOpen a separeate window
MedicaidOpen a separeate window
MedicareOpen a separeate window
MGI Pharma, Inc.Open a separeate window
Monoclonal antibodyOpen a separeate window
MorphotekOpen a separeate window
MROpen a separeate window
Page Top

N
NeuroBloc®Open a separeate window
NHI (National Health Insurance) drug price revisionOpen a separeate window
NICEOpen a separeate window
NMEOpen a separeate window
Page Top

O
Off-label useOpen a separeate window
OTCOpen a separeate window
Page Top

P
Pariet®Open a separeate window
PipelineOpen a separeate window
PlaceboOpen a separeate window
POCOpen a separeate window
Prialt®Open a separeate window
Prescription pharmaceuticalsOpen a separeate window
Proton pump inhibitor (PPI)Open a separeate window
PsoriasisOpen a separeate window
Page Top

Q
QOLOpen a separeate window
Page Top

R
RoyaltyOpen a separeate window
Page Top

S
Seamless value chainOpen a separeate window
Sensitivity to currencyOpen a separeate window
Stronger Neo-Minophagen® COpen a separeate window
Switch OTCOpen a separeate window
Page Top

T
TNF-alphaOpen a separeate window
Transformation StrategyOpen a separeate window
T-614Open a separeate window
Page Top

U
Unmet medical needsOpen a separeate window
Page Top

Z
Zonegran®Open a separeate window
Page Top

Eisai product names
AcipHex®Open a separeate window
Actonel®Open a separeate window
Aloxi®Open a separeate window
Aricept® Open a separeate window
Dacogen®Open a separeate window
Eril®Open a separeate window
Gasmotin®Open a separeate window
Glufast®Open a separeate window
HumiraOpen a separeate window
Inovelon®Open a separeate window
NeuroBloc®Open a separeate window
Pariet®Open a separeate window
Prialt®Open a separeate window
Stronger Neo-Minophagen® COpen a separeate window
Zonegran®Open a separeate window
Page Top

New Eisai pharmaceuticals under development
E2007Open a separeate window
E2012Open a separeate window
E5564Open a separeate window
E7389Open a separeate window
KES524Open a separeate window
T-614Open a separeate window
Page Top

Eisai's businesses
Dramatic Leap PlanOpen a separeate window
European Knowledge CentreOpen a separeate window
Independent MarketingOpen a separeate window
Integrative neuroscienceOpen a separeate window
Integrative oncologyOpen a separeate window
MGI Pharma, Inc.Open a separeate window
MorphotekOpen a separeate window
Seamless value chainOpen a separeate window
Transformation StrategyOpen a separeate window
Page Top

Pharmaceuticals/treatments
Acetylcholin-esterase inhibitorOpen a separeate window
ANDAOpen a separeate window
BlockbusterOpen a separeate window
Branded drugOpen a separeate window
ComplianceOpen a separeate window
Compound (of matter) patentOpen a separeate window
Drug priceOpen a separeate window
GenericsOpen a separeate window
Managed careOpen a separeate window
MedicaidOpen a separeate window
MedicareOpen a separeate window
Monoclonal antibodyOpen a separeate window
MROpen a separeate window
NHI (National Health Insurance) drug price revisionOpen a separeate window
NICEOpen a separeate window
NMEOpen a separeate window
Off-label useOpen a separeate window
OTCOpen a separeate window
PipelineOpen a separeate window
PlaceboOpen a separeate window
POCOpen a separeate window
Prescription pharmaceuticalsOpen a separeate window
Proton pump inhibitor (PPI)Open a separeate window
PsoriasisOpen a separeate window
QOLOpen a separeate window
Switch OTCOpen a separeate window
TNF-alphaOpen a separeate window
Unmet medical needsOpen a separeate window
Page Top

Accounting
AdjustedOpen a separeate window
Cash IncomeOpen a separeate window
DOEOpen a separeate window
GAAPOpen a separeate window
In Process R&D ExpensesOpen a separeate window
RoyaltyOpen a separeate window
Sensitivity to currencyOpen a separeate window
   Understanding Eisai Page Top    
Bottom menu
   Privacy Policy  |   Terms of Use  |   Accessibility
Copyright(C) Eisai Co., Ltd All right reserved.